Report #2876359

Received Dec 4, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Injection site pain

Symptom narrative

Injection site pain; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of injection site pain in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: Injection site pain). The outcome of the injection site pain was resolved (duration 2 weeks). The reporter considered the injection site pain to be related to Shingrix. The company considered the injection site pain to be related to Shingrix. Additional Information: GSK Receipt Date:02-DEC-2025 Reporter reported that patient received her first dose of Shingrix and that local injection site pain was severe The batch number was not provided and a request for this information has been made